GlassScriptPhysician profile
Laura Keeling
NPI 1710410725
$31,194.39
in general payments reported to CMS, 2019-2025
8 companies · $503 in 2025
The $503 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $25K · 2023: $5,663 · 2024: $416 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,542 · Food and Beverage: $2,026 · Travel and Lodging: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,541.67 |
| Food and Beverage | $2,026.46 |
| Travel and Lodging | $1,013.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $15,000.00 | 2022 | |
| Smith+Nephew, INC. | $7,263.73 | 2022-2024 | Microraptor, Q-Fix, Cap-Fix |
| Mid-Atlantic Surgical Systems, LLC | $6,200.63 | 2022-2023 | |
| Stryker Corporation | $1,928.34 | 2023-2024 | Blueprint Patient Specific Instrumentation, Salvation, 1788 |
| Linvatec Corporation | $520.05 | 2023-2025 | Biobrace 23mm, Linvatec Shoulder Arthroscopy, Linvatec Extremities |
| Avanos Medical | $146.01 | 2025 | On-Q Pump and Accessories |
| Supreme Orthopedic Systems, LLC | $118.01 | 2024 | |
| Fidia Pharma USA INC. | $17.62 | 2025 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Keeling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.